Today: 8 June 2026
Northern Star Resources share price slips after gold’s shock fall; what ASX:NST investors watch next week
31 January 2026
2 mins read

Northern Star Resources share price slips after gold’s shock fall; what ASX:NST investors watch next week

Sydney, Jan 31, 2026, 16:49 AEDT — Market closed

  • On Friday, Northern Star ended the session down 1.87%, closing at A$28.94.
  • The steep sell-off in gold late last week has recalibrated risk heading into Monday’s open.
  • The upcoming catalyst for the company is the half-year results, set for release on Feb. 12.

Northern Star Resources shares slipped 1.87% to close at A$28.94 on Friday, after fluctuating between A$28.30 and A$29.75 during the session. This decline erased much of Thursday’s 3.11% gain. Trading volume hit roughly 13.15 million shares.

This matters now since the stock has turned into a fast barometer for bullion sentiment once more. As the Australian market stays closed over the weekend, investors are eyeing gold prices and the U.S. dollar closely, trying to gauge if Friday’s dip was a simple shakeout or the beginning of a bigger decline.

Gold offered no refuge. Spot gold plunged 9.5% on Friday, retreating sharply after hitting a record high the day before. The sell-off came after Donald Trump announced Kevin Warsh as his pick to lead the Federal Reserve. “Whether we look at the dollar or expectations for real yields, a combination of these drivers has helped trigger profit-taking,” explained Suki Cooper at Standard Chartered Bank. Nicky Shiels from MKS PAMP SA described January as “the most volatile month in precious metals history.” Reuters

The broader market slipped as well. The S&P/ASX 200 dropped 0.65% on Friday, dragged down by miners who had led gains earlier in the week, Morningstar reported alongside Australian Associated Press.

Company fundamentals are still driving results behind the scenes. Northern Star’s December-quarter report last week showed it sold 348,061 ounces of gold at an all-in sustaining cost (AISC) of A$2,937 per ounce, with cash and bullion totaling A$1.176 billion. CEO Stuart Tonkin attributed a “softer December quarter” to “one-off operational events,” while the firm highlighted progress on growth projects and flagged more free cash flow as hedges unwind. NSR Limited

In January, Northern Star trimmed its FY26 production forecast to 1.6–1.7 million ounces from the earlier 1.7–1.85 million ounces. It also raised the FY26 AISC estimate to A$2,600–2,800 per ounce. The company attributed these updates mainly to lower gold sales and increased royalties linked to higher gold prices. Its sustaining capital guidance remained steady at around A$750 million.

AISC is a widely used industry metric that aims to reflect the true cost of ongoing production, beyond just daily mining expenses. It includes sustaining capital and site overheads on top of operating costs, meaning it can spike if output falls or expenses increase.

Gold prices have hovered near record highs this year, but gold equities haven’t consistently matched that momentum. Macquarie points out that many broker models still use long-term gold price assumptions well below current spot levels, limiting upside in target prices. January saw big moves for Evolution Mining, Regis Resources, and Newmont, mirroring bullion’s volatility despite the metal’s strong gains.

There’s a sharper downside to consider as well. If gold keeps sliding and risk appetite worsens, miners tend to tank even more sharply — costs don’t drop as quickly, making it tougher to uphold guidance. Any slip-up before earnings season would only worsen the hit.

Northern Star’s next key milestone is its half-year results on Feb. 12. Until then, Monday’s market open could act as a test of whether last week’s drop in gold continues to weigh on stocks.

Stock Market Today

  • KOSPI Index Plunges Amid Global Market Turmoil
    June 8, 2026, 9:07 AM EDT. South Korea's KOSPI experienced a sharp crash triggered by margin stress in chip stocks and a circuit breaker trading halt. The selloff in global markets was fueled by a strong U.S. jobs report signaling prolonged high interest rates, fears of a yen carry trade unwind amid Bank of Japan tightening, and a crypto selloff following Zcash network vulnerabilities. U.S. futures rebounded slightly as chip stocks recovered, with investors focused on upcoming inflation data and SpaceX's anticipated IPO. Rising Middle East tensions keep oil prices elevated near $94 per barrel. The volatile market reflects growing concerns over liquidity absorption from the SpaceX listing, geopolitical risks, and tightening monetary policies globally.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Disney stock heads into new week with Iger succession report hanging over DIS shares
Previous Story

Disney stock heads into new week with Iger succession report hanging over DIS shares

Wilmar International share price slips to S$3.39 as palm oil turns lower — what to watch before Feb 26 results
Next Story

Wilmar International share price slips to S$3.39 as palm oil turns lower — what to watch before Feb 26 results

Go toTop